January 17, 2018 / 12:06 PM / a month ago

BRIEF-Gemphire Completes Patient Enrollment In Indigo-1 Trial

Jan 17 (Reuters) - Gemphire Therapeutics Inc:

* GEMPHIRE COMPLETES PATIENT ENROLLMENT IN INDIGO-1 TRIAL IN SEVERE HYPERTRIGLYCERIDEMIA (SHTG) PATIENTS

* GEMPHIRE THERAPEUTICS INC - ON TRACK TO REPORT TOP-LINE DATA FROM PHASE 2B TRIAL IN Q2 OF 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below